Gabapentin and Pregabalin will be reclassified to Schedule 3 Controlled Drugs (CDs) from 1 April 2019.
Want the latest pharmacy news and updates straight to your inbox?
Sign up to our regular newsletter for the latest guidance, news, events and CPD opportunities.
Sign Up